New drug BBT002 aims to tackle COPD and chronic sinusitis in early trial

NCT ID NCT06944925

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests a new drug, BBT002, in healthy volunteers and people with chronic obstructive pulmonary disease (COPD) or chronic rhinosinusitis with nasal polyps (CRSwNP). The trial is double-blind and placebo-controlled, meaning some participants get the drug and some get a dummy treatment. The main goal is to check safety and how the body handles the drug, with a secondary look at whether it helps symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
BBT002
What this could lead to
If successful, BBT002 could become a new treatment option for people with COPD or chronic sinusitis with nasal polyps.
What could go wrong
This is an early phase 1 trial, so the main goal is safety, not effectiveness. The drug may not work or could have side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aleksandre Aladashvili Clinic LLC

    RECRUITING

    Tbilisi, 0198, Georgia

  • Centrum Nowoczesnych Terapii Dobry Lekarz Sp. z o.o.

    NOT_YET_RECRUITING

    Krakow, 31-011, Poland

  • Equity Medical - Owensboro

    NOT_YET_RECRUITING

    Owensboro, Kentucky, 42303, United States

  • Equity Medical Bowling Green

    RECRUITING

    Bowling Green, Kentucky, 42104, United States

  • Equity Medical LLC

    RECRUITING

    New York, New York, 10023, United States

  • Geo Hospitals Tbilisi Multiprofile Medical Center

    RECRUITING

    Tbilisi, 0198, Georgia

  • LEPL The First University Clinic of Tbilisi State Medical University

    RECRUITING

    Tbilisi, 0198, Georgia

  • Linear Clinical Research

    RECRUITING

    Perth, Western Australia, 6009, Australia

  • Ltd Aversi Clinic

    RECRUITING

    Tbilisi, 0198, Georgia

  • Momentum Clinical Research

    RECRUITING

    Brisbane, 4068, Australia

  • Momentum Clinical Research

    RECRUITING

    Pukekohe, 2120, New Zealand

  • Momentum Clinical Research

    RECRUITING

    Wellington, 6021, New Zealand

  • Momentum Clinical Research Hamilton

    NOT_YET_RECRUITING

    Rotorua, Hamilton, 3010, New Zealand

  • Uniwersyteckie Centrum Kliniczne Osrodka Badan Klinicznych Wczesnych Faz

    NOT_YET_RECRUITING

    Gdansk, 80-214, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.